JP2005533789A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533789A5
JP2005533789A5 JP2004513217A JP2004513217A JP2005533789A5 JP 2005533789 A5 JP2005533789 A5 JP 2005533789A5 JP 2004513217 A JP2004513217 A JP 2004513217A JP 2004513217 A JP2004513217 A JP 2004513217A JP 2005533789 A5 JP2005533789 A5 JP 2005533789A5
Authority
JP
Japan
Prior art keywords
mono
poly
cyclic
substituents
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004513217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533789A (ja
JP4718172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/018262 external-priority patent/WO2003106381A2/en
Publication of JP2005533789A publication Critical patent/JP2005533789A/ja
Publication of JP2005533789A5 publication Critical patent/JP2005533789A5/ja
Application granted granted Critical
Publication of JP4718172B2 publication Critical patent/JP4718172B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004513217A 2002-06-12 2003-06-11 ヒトadam−10インヒビター Expired - Fee Related JP4718172B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38832602P 2002-06-12 2002-06-12
US60/388,326 2002-06-12
PCT/US2003/018262 WO2003106381A2 (en) 2002-06-12 2003-06-11 Human adam-10 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010142096A Division JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトadam−10インヒビター

Publications (3)

Publication Number Publication Date
JP2005533789A JP2005533789A (ja) 2005-11-10
JP2005533789A5 true JP2005533789A5 (cg-RX-API-DMAC7.html) 2011-02-24
JP4718172B2 JP4718172B2 (ja) 2011-07-06

Family

ID=29736461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004513217A Expired - Fee Related JP4718172B2 (ja) 2002-06-12 2003-06-11 ヒトadam−10インヒビター
JP2010142096A Pending JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトadam−10インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010142096A Pending JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトadam−10インヒビター

Country Status (7)

Country Link
US (5) US7629341B2 (cg-RX-API-DMAC7.html)
EP (3) EP1511488B1 (cg-RX-API-DMAC7.html)
JP (2) JP4718172B2 (cg-RX-API-DMAC7.html)
AU (2) AU2003237532B2 (cg-RX-API-DMAC7.html)
CA (1) CA2485346C (cg-RX-API-DMAC7.html)
ES (1) ES2425013T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003106381A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517884B2 (en) * 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
AU2003237532B2 (en) 2002-06-12 2009-07-30 Symphony Evolution, Inc. Human ADAM-10 inhibitors
WO2004089294A2 (en) 2003-04-04 2004-10-21 Incyte Corporation Compositions, methods and kits relating to her-2 cleavage
EP1623995A1 (en) 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibitors of L1 and ADAM10 for the treatment of carcinomas
US20070190079A1 (en) * 2004-10-29 2007-08-16 Kalypsys, Inc. Methods for the selective modulation of ppar
RU2384576C2 (ru) * 2004-10-29 2010-03-20 Калипсис, Инк Сульфонил-замещенные бициклические соединения в качестве модуляторов ppar
EP1896580A2 (en) * 2005-04-07 2008-03-12 Novartis Vaccines and Diagnostics, Inc. Adam10 in cancer diagnosis, detection and treatment
KR101464767B1 (ko) * 2005-10-25 2014-11-24 칼립시스, 인코포레이티드 Ppar의 조절자의 염 및 대사질환을 치료하는 방법
WO2007084488A2 (en) 2006-01-13 2007-07-26 Vanderbilt University Adam10 and its uses related to infection
CN100506804C (zh) * 2006-01-26 2009-07-01 于学敏 羟苯磺酸烷基吡嗪药物及其制备方法和应用
US20070249519A1 (en) * 2006-04-20 2007-10-25 Kalypsys, Inc. Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
AR060937A1 (es) * 2006-05-16 2008-07-23 Kalypsys Inc Compuestos biciclicos sustituidos con sulfonilo como moduladores de ppar
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
WO2009052200A2 (en) * 2007-10-16 2009-04-23 Symphony Evolution, Inc. Human adam-10 inhibitors
ES2620634T3 (es) 2008-10-09 2017-06-29 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Activadores de piruvato quinasa humana
EP2482817A1 (en) * 2009-10-01 2012-08-08 Symphony Evolution, Inc. Methods of treating aneurysmal dilatation, blood vessel wall weakness and specifically abdominal aortic and thoracic aneurysm using matrix metalloprotease-2 inhibitors
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
JP5888667B2 (ja) * 2010-04-30 2016-03-22 国立大学法人名古屋大学 Adam作用阻害物質のスクリーニング方法、仮足の保持方法、仮足保持剤、仮足の制御物質のスクリーニング方法、及びadam作用阻害剤
EP2637679A4 (en) 2010-11-09 2015-09-23 Univ Chicago ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASES AND THERAPEUTICS
WO2014028334A1 (en) * 2012-08-11 2014-02-20 Symphony Evolution, Inc. Selective mmp inhibitors
WO2015112842A1 (en) * 2014-01-24 2015-07-30 Ntercept, Llc Methods and compositions for immune dis-inhibition
CA2962251A1 (en) 2014-10-03 2016-04-07 Ntercept, Llc Compositions and methods for inhibiting the biological activity of soluble biomolecules
CN108135850A (zh) 2015-07-29 2018-06-08 纳米提克斯有限责任公司 用于清除可溶性生物分子的模块化组合物及其相关方法
US11065345B2 (en) 2017-01-04 2021-07-20 Nanotics, Llc Methods for assembling scavenging particles
US20210130430A1 (en) 2018-05-14 2021-05-06 Werewolf Therapeutics, Inc. Activatable cytokine polypeptides and methods of use thereof
CN108947850B (zh) * 2018-07-23 2021-05-18 蚌埠中实化学技术有限公司 一种3,4,5-三氟苯胺的制备方法
BR112021022666A2 (pt) 2019-05-14 2022-03-29 Werewolf Therapeutics Inc Frações de separação e seus métodos e uso
BR112022009110A2 (pt) 2019-11-14 2022-07-26 Werewolf Therapeutics Inc Polipeptídeos de citocina ativáveis e métodos de uso destes
CN113563235B (zh) * 2021-07-28 2023-04-11 上海毕得医药科技股份有限公司 一种3-(卤代苯氧基)苯磺酰氯衍生物的合成方法
JP2025507975A (ja) * 2022-03-08 2025-03-21 ノバ サウスイースタン ユニバーシティー ディスインテグリンおよびメタロプロテアーゼ10(adam10)の酵素・基質選択的エキソサイト阻害剤を用いた関節リウマチ(ra)の処置方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1016245A (en) 1962-11-06 1966-01-05 Ici Ltd Manufacture of polysulphones
US4213775A (en) * 1977-07-28 1980-07-22 Ube Industries, Ltd. Diphenyl ether derivatives and herbicidal compositions containing the same
DE3107700A1 (de) * 1981-02-28 1982-09-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von aromatischen sulfohalogeniden
WO1991013146A1 (en) 1990-03-01 1991-09-05 The Upjohn Company Ruminal bacterium for preventing acute lactic acidosis
DE4015834A1 (de) * 1990-05-17 1991-11-21 Bayer Ag Phenoxyphenylsulfonylverbindungen
US5215549A (en) 1991-05-08 1993-06-01 Mobil Oil Corporation Thioester derived hindered phenols and aryl-amines as antioxidant and antiwear additives
DE4327026A1 (de) 1993-08-12 1995-02-16 Bayer Ag Arylsulfonyloxyphosphonsäurederivate
CA2218503C (en) 1995-04-20 2001-07-24 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
JP3837761B2 (ja) * 1995-08-04 2006-10-25 住友精化株式会社 ハロベンゼンスルホニルクロリド類の製造方法
DE19537334A1 (de) 1995-10-09 1997-04-10 Hoechst Ag Antiadhäsive Piperidin- und Pyrrolidin-Carbonsäuren
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
US5753653A (en) * 1995-12-08 1998-05-19 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
EA003294B1 (ru) * 1995-12-08 2003-04-24 Агурон Фармасьютикалс, Инк. Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
HUP0000505A3 (en) 1996-08-28 2001-12-28 Procter & Gamble Saturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them
EP0963432A4 (en) 1996-08-29 2002-11-20 Univ California KUZ, NEW FAMILY OF METALLOPROTEASES
WO1998027069A1 (en) 1996-12-17 1998-06-25 Fujisawa Pharmaceutical Co., Ltd. Piperazine compounds as inhibitors of mmp or tnf
JP3563411B2 (ja) * 1997-01-23 2004-09-08 エフ・ホフマン−ラ ロシュ アーゲー スルファミド−メタロプロテアーゼ阻害剤
NZ336836A (en) 1997-02-11 2001-02-23 Pfizer Arylsulfonyl hydroxamic acid derivatives suitable for a broad range of medicinal treatments
EP0973748A1 (en) * 1997-04-01 2000-01-26 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US5922546A (en) 1997-08-25 1999-07-13 Smithkline Beecham Corporation Human disintegrin metalloprotease KUZ gene
JP4327915B2 (ja) * 1998-03-30 2009-09-09 株式会社デ・ウエスタン・セラピテクス研究所 スルフォンアミド誘導体
GT199900044A (es) * 1998-04-10 2000-09-14 Procedimientos para preparar haluros de fenoxifenilsulfonilo.
BR9910678A (pt) 1998-05-14 2001-10-02 Du Pont Pharm Co Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto
WO2000009492A1 (en) 1998-08-12 2000-02-24 Pfizer Products Inc. Tace inhibitors
US6509337B1 (en) 1998-09-17 2003-01-21 Pfizer Inc. Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
AR035313A1 (es) 1999-01-27 2004-05-12 Wyeth Corp Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
US6225311B1 (en) 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
JP2000247975A (ja) 1999-02-25 2000-09-12 Nissan Chem Ind Ltd ヘテロ環縮合ピリミジノン誘導体及びそれらを含む除草剤
US6387901B1 (en) 1999-07-06 2002-05-14 Pfizer Inc Alkyne containing metalloproteinase inhibitors
EP1081137A1 (en) 1999-08-12 2001-03-07 Pfizer Products Inc. Selective inhibitors of aggrecanase in osteoarthritis treatment
AU2001233034A1 (en) 2000-01-27 2001-08-07 American Cyanamid Company Method for preparing alpha-sulfonyl hydroxamic acid derivatives
US6664291B2 (en) * 2000-03-31 2003-12-16 Pfizer, Inc. Malonamic acids and derivatives thereof as thyroid receptor ligands
JP4635162B2 (ja) * 2000-04-27 2011-02-16 独立行政法人理化学研究所 芳香族ジアミンの製造方法及び芳香族ジアミン化合物
AU2002255613A1 (en) 2001-02-27 2002-09-12 Axys Pharmaceuticals, Inc. Piperazine derivatives as metalloprotease inhibitors
CA2357110A1 (en) 2001-04-11 2002-10-11 American Cyanamid Company Method for the treatment of polycystic kidney disease
JP4365102B2 (ja) 2001-04-26 2009-11-18 コーロン ライフ サイエンス インク 新規なスルホンアミド誘導体、その中間体化合物、及びその製造方法、並びにスルホンアミド誘導体を含む薬剤学的組成物
US6399823B1 (en) * 2001-04-30 2002-06-04 General Electric Company Method for producing phosgene
JP2005507937A (ja) 2001-11-01 2005-03-24 ワイス・ホールディングズ・コーポレイション マトリックスメタロプロテイナーゼおよびtace阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
CN1173960C (zh) 2001-12-06 2004-11-03 中国人民解放军军事医学科学院毒物药物研究所 取代六元氮杂环类化合物及其作为神经调节剂的用途
WO2003051825A1 (en) * 2001-12-14 2003-06-26 Exelixis, Inc. Human adam-10 inhibitors
US7504537B2 (en) 2001-12-27 2009-03-17 Dainippon Sumitomo Pharma Co., Ltd. Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient
WO2003057214A1 (en) 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
US7488754B2 (en) 2002-04-05 2009-02-10 Wyeth Method for the treatment of polycystic kidney disease
AU2003237532B2 (en) 2002-06-12 2009-07-30 Symphony Evolution, Inc. Human ADAM-10 inhibitors
MXPA05001603A (es) 2002-08-13 2005-04-25 Warner Lambert Co Derivados monociclicos como inhibidores de metaloproteinasa de matriz.
EP1400244A1 (en) 2002-09-17 2004-03-24 Warner-Lambert Company LLC New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
WO2004071390A2 (en) 2003-02-14 2004-08-26 Applied Research Systems Ars Holding N.V. Piperazine-2-carboxamide derivatives
JP2006517960A (ja) 2003-02-18 2006-08-03 ファイザー インコーポレイテッド C型肝炎ウイルスの阻害剤、それを使用する組成物および治療法
WO2006076442A2 (en) 2005-01-14 2006-07-20 Janssen Pharmaceutica N.V. Triazolopyrimidine derivatives
CA2620414A1 (en) 2005-08-26 2007-03-01 Methylgene Inc. Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
EP1937632A1 (en) 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds

Similar Documents

Publication Publication Date Title
JP2024504932A5 (cg-RX-API-DMAC7.html)
JP2006505543A5 (cg-RX-API-DMAC7.html)
JP2012510502A5 (cg-RX-API-DMAC7.html)
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
JP2003521537A5 (cg-RX-API-DMAC7.html)
JP2007503202A5 (cg-RX-API-DMAC7.html)
JP2006151984A5 (cg-RX-API-DMAC7.html)
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
JP2014516360A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2007502804A5 (cg-RX-API-DMAC7.html)
JP2005501904A5 (cg-RX-API-DMAC7.html)
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
JP2005539045A5 (cg-RX-API-DMAC7.html)
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
AR050518A1 (es) Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv
JP2004518658A5 (cg-RX-API-DMAC7.html)
JP2020502116A5 (cg-RX-API-DMAC7.html)
RU2401267C2 (ru) Замещенные производные бензохинолизина
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
AR065297A1 (es) Formulaciones biodisponibles de compuestos heterociclicos
JP2022507795A5 (cg-RX-API-DMAC7.html)
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
JP2011510026A5 (cg-RX-API-DMAC7.html)
TR200200745T2 (tr) Fenilasetik asit türevleri için proses.